Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v8-FR
Language English French
Date Updated 2018-11-15 2018-10-10
Drug Identification Number 02342227 02342227
Brand name CERVARIX CERVARIX
Common or Proper name Human Papillomavirus vaccine Types 16 and 18 Human Papillomavirus vaccine Types 16 and 18
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Strength(s) 20MCG 20MCG 20MCG 20MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's 1's
ATC code J07BM J07BM
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2018-04-09 2018-04-09
Estimated end date 2018-11-15 2018-11-15
Actual end date 2018-11-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Supply currently unavailable
Health Canada comments